http://www.pharmaceutical-technology.com/news/hdt-bio-navigates-vaccine-strategy-in-a-changing-covid-19-landscape/
0
0
10/24/23 at 1:20pm
Organization
Pharmaceutical Technology
Author
Justine Ra
33 words
0
Comments
Amidst a changing, complex Covid-19 marketplace, HDT-Bio looks towards harnessing multivalence for its Covid-19 candidate, HDT-301.
You are the first to view
Create an account
or login to join the discussion